

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 7.92578362 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 7.92578362 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.33840928 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.95976042 |
| 5 | endocrine pancreas development (GO:0031018) | 5.50897654 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 5.19155554 |
| 7 | COPII vesicle coating (GO:0048208) | 5.18287140 |
| 8 | exocrine pancreas development (GO:0031017) | 5.06008173 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.00127234 |
| 10 | cellular glucuronidation (GO:0052695) | 4.89778026 |
| 11 | glucuronate metabolic process (GO:0019585) | 4.68752541 |
| 12 | uronic acid metabolic process (GO:0006063) | 4.68752541 |
| 13 | glandular epithelial cell differentiation (GO:0002067) | 4.32456589 |
| 14 | signal peptide processing (GO:0006465) | 4.25243742 |
| 15 | peptide hormone processing (GO:0016486) | 4.22390423 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.18231892 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 4.18231892 |
| 18 | intestinal absorption (GO:0050892) | 4.16088759 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 3.95863571 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95863571 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 3.88301551 |
| 22 | auditory receptor cell differentiation (GO:0042491) | 3.81936186 |
| 23 | angiotensin maturation (GO:0002003) | 3.79791351 |
| 24 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.72437219 |
| 25 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.72437219 |
| 26 | desmosome organization (GO:0002934) | 3.68221964 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 3.68167347 |
| 28 | drug transmembrane transport (GO:0006855) | 3.67765779 |
| 29 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.66646072 |
| 30 | flavonoid metabolic process (GO:0009812) | 3.66207029 |
| 31 | ethanol oxidation (GO:0006069) | 3.56061491 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53772058 |
| 33 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.52933110 |
| 34 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.51066219 |
| 35 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.51035222 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 3.44361081 |
| 37 | ER overload response (GO:0006983) | 3.44269238 |
| 38 | vesicle coating (GO:0006901) | 3.37828238 |
| 39 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.37701847 |
| 40 | bile acid and bile salt transport (GO:0015721) | 3.31944097 |
| 41 | intestinal epithelial cell development (GO:0060576) | 3.29922993 |
| 42 | positive regulation of nuclease activity (GO:0032075) | 3.26545331 |
| 43 | protein maturation by protein folding (GO:0022417) | 3.24956041 |
| 44 | sequestering of metal ion (GO:0051238) | 3.24649539 |
| 45 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.23666734 |
| 46 | bile acid metabolic process (GO:0008206) | 3.23491756 |
| 47 | digestion (GO:0007586) | 3.22419607 |
| 48 | positive regulation of glycolytic process (GO:0045821) | 3.22244922 |
| 49 | peptide catabolic process (GO:0043171) | 3.18235232 |
| 50 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.15752945 |
| 51 | drug metabolic process (GO:0017144) | 3.13865939 |
| 52 | drug transport (GO:0015893) | 3.13804623 |
| 53 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.11921098 |
| 54 | daunorubicin metabolic process (GO:0044597) | 3.11407150 |
| 55 | polyketide metabolic process (GO:0030638) | 3.11407150 |
| 56 | doxorubicin metabolic process (GO:0044598) | 3.11407150 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 3.10309789 |
| 58 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.10038472 |
| 59 | negative regulation of complement activation (GO:0045916) | 3.08765969 |
| 60 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.08255195 |
| 61 | ethanol metabolic process (GO:0006067) | 3.07994152 |
| 62 | cellular response to unfolded protein (GO:0034620) | 3.06258713 |
| 63 | transcytosis (GO:0045056) | 3.02855505 |
| 64 | tyrosine metabolic process (GO:0006570) | 3.02453346 |
| 65 | type B pancreatic cell development (GO:0003323) | 3.00959318 |
| 66 | positive regulation of insulin secretion (GO:0032024) | 3.00401589 |
| 67 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.98969750 |
| 68 | primary alcohol catabolic process (GO:0034310) | 2.98401989 |
| 69 | ER-nucleus signaling pathway (GO:0006984) | 2.97104200 |
| 70 | regulation of protein activation cascade (GO:2000257) | 2.95964062 |
| 71 | cellular response to topologically incorrect protein (GO:0035967) | 2.95853982 |
| 72 | valine metabolic process (GO:0006573) | 2.95387004 |
| 73 | thyroid hormone generation (GO:0006590) | 2.95349961 |
| 74 | regulation of nuclease activity (GO:0032069) | 2.95167077 |
| 75 | aromatic amino acid family catabolic process (GO:0009074) | 2.94846540 |
| 76 | homocysteine metabolic process (GO:0050667) | 2.94702295 |
| 77 | urate metabolic process (GO:0046415) | 2.94684822 |
| 78 | regulation of glucokinase activity (GO:0033131) | 2.94511852 |
| 79 | regulation of hexokinase activity (GO:1903299) | 2.94511852 |
| 80 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.93198095 |
| 81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.91702107 |
| 82 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.89328732 |
| 83 | regulation of guanylate cyclase activity (GO:0031282) | 2.89264843 |
| 84 | excretion (GO:0007588) | 2.89213097 |
| 85 | sodium ion homeostasis (GO:0055078) | 2.85652563 |
| 86 | negative regulation of digestive system process (GO:0060457) | 2.83958017 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 2.82180961 |
| 88 | regulation of complement activation (GO:0030449) | 2.82115721 |
| 89 | cysteine metabolic process (GO:0006534) | 2.81461882 |
| 90 | urea metabolic process (GO:0019627) | 2.80625093 |
| 91 | phospholipid efflux (GO:0033700) | 2.80438387 |
| 92 | urea cycle (GO:0000050) | 2.79729927 |
| 93 | 4-hydroxyproline metabolic process (GO:0019471) | 2.78809708 |
| 94 | glandular epithelial cell development (GO:0002068) | 2.77730192 |
| 95 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.76886489 |
| 96 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.76886489 |
| 97 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.76886489 |
| 98 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.75454775 |
| 99 | response to endoplasmic reticulum stress (GO:0034976) | 2.75444672 |
| 100 | protein autoprocessing (GO:0016540) | 2.75324168 |
| 101 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.74914616 |
| 102 | peptidyl-asparagine modification (GO:0018196) | 2.73382417 |
| 103 | renal system process involved in regulation of blood volume (GO:0001977) | 2.73063600 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 2.72233984 |
| 105 | biotin metabolic process (GO:0006768) | 2.72174792 |
| 106 | thyroid hormone metabolic process (GO:0042403) | 2.71739494 |
| 107 | drug catabolic process (GO:0042737) | 2.70384880 |
| 108 | toxin metabolic process (GO:0009404) | 2.69995572 |
| 109 | primary alcohol metabolic process (GO:0034308) | 2.69826924 |
| 110 | insulin secretion (GO:0030073) | 2.67606377 |
| 111 | NADH metabolic process (GO:0006734) | 2.67574523 |
| 112 | glyoxylate metabolic process (GO:0046487) | 2.64685826 |
| 113 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.64478142 |
| 114 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64444255 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 2.64430137 |
| 116 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63529558 |
| 117 | protein carboxylation (GO:0018214) | 2.63529558 |
| 118 | hair cell differentiation (GO:0035315) | 2.63183002 |
| 119 | inner ear receptor cell differentiation (GO:0060113) | 2.63172891 |
| 120 | acylglycerol homeostasis (GO:0055090) | 2.63025660 |
| 121 | triglyceride homeostasis (GO:0070328) | 2.63025660 |
| 122 | GDP-mannose metabolic process (GO:0019673) | 2.62323296 |
| 123 | fatty acid oxidation (GO:0019395) | 2.61775913 |
| 124 | reverse cholesterol transport (GO:0043691) | 2.60507486 |
| 125 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.59506131 |
| 126 | hormone catabolic process (GO:0042447) | 2.59479389 |
| 127 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.59241207 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 2.57908915 |
| 129 | branched-chain amino acid catabolic process (GO:0009083) | 2.57340058 |
| 130 | multicellular organismal water homeostasis (GO:0050891) | 2.56985160 |
| 131 | positive regulation of peptide hormone secretion (GO:0090277) | 2.56913520 |
| 132 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.56885227 |
| 133 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.56738165 |
| 134 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.56738165 |
| 135 | endocrine process (GO:0050886) | 2.56738165 |
| 136 | lipid oxidation (GO:0034440) | 2.56115113 |
| 137 | digestive system process (GO:0022600) | 2.54612107 |
| 138 | protein N-linked glycosylation (GO:0006487) | 2.54358875 |
| 139 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.54242362 |
| 140 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.53773286 |
| 141 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.53765662 |
| 142 | branched-chain amino acid metabolic process (GO:0009081) | 2.53438676 |
| 143 | regulation of bile acid biosynthetic process (GO:0070857) | 2.52932912 |
| 144 | regulation of cholesterol metabolic process (GO:0090181) | 2.52683297 |
| 145 | protein-lipid complex assembly (GO:0065005) | 2.52679180 |
| 146 | peptide metabolic process (GO:0006518) | 2.52222613 |
| 147 | surfactant homeostasis (GO:0043129) | 2.52162273 |
| 148 | regulation of cholesterol esterification (GO:0010872) | 2.51830352 |
| 149 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.51382237 |
| 150 | phosphate ion transmembrane transport (GO:0035435) | 2.50765827 |
| 151 | high-density lipoprotein particle remodeling (GO:0034375) | 2.50198482 |
| 152 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.48793960 |
| 153 | nitric oxide mediated signal transduction (GO:0007263) | 2.48534268 |
| 154 | fatty acid catabolic process (GO:0009062) | 2.48509914 |
| 155 | vitamin transmembrane transport (GO:0035461) | 2.48172165 |
| 156 | arginine metabolic process (GO:0006525) | 2.47906795 |
| 157 | O-glycan processing (GO:0016266) | 2.47734075 |
| 158 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.47390943 |
| 159 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.45990897 |
| 160 | actin filament depolymerization (GO:0030042) | 2.45682489 |
| 161 | regulation of insulin secretion (GO:0050796) | 2.45659416 |
| 162 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.45422798 |
| 163 | positive regulation of peptide secretion (GO:0002793) | 2.45161300 |
| 164 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.45115252 |
| 165 | bile acid biosynthetic process (GO:0006699) | 2.44564574 |
| 166 | glycoside metabolic process (GO:0016137) | 2.44275584 |
| 167 | complement activation, classical pathway (GO:0006958) | 2.44095242 |
| 168 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.42823612 |
| 169 | phenol-containing compound catabolic process (GO:0019336) | 2.42803893 |
| 170 | phospholipid homeostasis (GO:0055091) | 2.42424262 |
| 171 | vitamin transport (GO:0051180) | 2.42135859 |
| 172 | renal absorption (GO:0070293) | 2.41641957 |
| 173 | glutathione derivative metabolic process (GO:1901685) | 2.41417231 |
| 174 | glutathione derivative biosynthetic process (GO:1901687) | 2.41417231 |
| 175 | retinol metabolic process (GO:0042572) | 2.40803816 |
| 176 | xenobiotic catabolic process (GO:0042178) | 2.40539919 |
| 177 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.39686458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.57980639 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.55368294 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.07443933 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.01453725 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00897264 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.50141407 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.36586948 |
| 8 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.09013777 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.08716431 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.75048724 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.69468137 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66951055 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.52398135 |
| 14 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.44043369 |
| 15 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.34959963 |
| 16 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.29543909 |
| 17 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.17921519 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.07625597 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07559282 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97394824 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89831931 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.88711429 |
| 23 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.88328442 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84252684 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.79027011 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75851006 |
| 27 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.69945303 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67221220 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65431472 |
| 30 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.65069972 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59544649 |
| 32 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.57711431 |
| 33 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.52030985 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.51138195 |
| 35 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.44497261 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43961893 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41936415 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.41306802 |
| 39 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36316486 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35566285 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26675175 |
| 42 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23991962 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23055016 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21814948 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21747209 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20993389 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19985569 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18100233 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17371144 |
| 50 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16553987 |
| 51 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.16522184 |
| 52 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14626841 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14444622 |
| 54 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.13982122 |
| 55 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13672960 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13507420 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12479607 |
| 58 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11006998 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10786072 |
| 60 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10651035 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10600855 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09570407 |
| 63 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08204906 |
| 64 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07195351 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06089501 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05428483 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05283654 |
| 68 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03854671 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01283258 |
| 70 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01222477 |
| 71 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00964386 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98256446 |
| 73 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.96419661 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95287369 |
| 75 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95126276 |
| 76 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95126276 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95109806 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93098212 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92086904 |
| 80 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91380041 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91272776 |
| 82 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90375213 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88268475 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88000072 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86486939 |
| 86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85547332 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85055733 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85010696 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83609958 |
| 90 | * AR_21909140_ChIP-Seq_LNCAP_Human | 0.83506354 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83427995 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83427995 |
| 93 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.82797929 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82641067 |
| 95 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.80841137 |
| 96 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.80833813 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80530144 |
| 98 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80501923 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80326105 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79970260 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79057240 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78609850 |
| 103 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77978970 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77825515 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77810657 |
| 106 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.77703062 |
| 107 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.76694837 |
| 108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76511745 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75895561 |
| 110 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.75821540 |
| 111 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.75715133 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75433095 |
| 113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75112005 |
| 114 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74812358 |
| 115 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.74555010 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74446789 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73986669 |
| 118 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73004010 |
| 119 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.72778641 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.72491689 |
| 121 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.68287628 |
| 122 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.67998005 |
| 123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67050143 |
| 124 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66691625 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66337890 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66300611 |
| 127 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65974282 |
| 128 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.65401841 |
| 129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.64604061 |
| 130 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.64522792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.37573008 |
| 2 | MP0005365_abnormal_bile_salt | 4.30660749 |
| 3 | MP0001666_abnormal_nutrient_absorption | 3.51646528 |
| 4 | MP0003283_abnormal_digestive_organ | 3.42650779 |
| 5 | MP0003195_calcinosis | 3.32653973 |
| 6 | MP0005220_abnormal_exocrine_pancreas | 3.14694804 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.09432673 |
| 8 | MP0004043_abnormal_pH_regulation | 3.06750421 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 2.93708261 |
| 10 | MP0005360_urolithiasis | 2.86641258 |
| 11 | MP0005083_abnormal_biliary_tract | 2.83096609 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.70494919 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.64892987 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.60032369 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.57137467 |
| 16 | MP0001944_abnormal_pancreas_morphology | 2.55538905 |
| 17 | MP0002693_abnormal_pancreas_physiology | 2.52034077 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.48044617 |
| 19 | MP0003252_abnormal_bile_duct | 2.46288283 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.45766551 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41321730 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.38644400 |
| 23 | MP0000678_abnormal_parathyroid_gland | 2.33063974 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 2.32939568 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 2.25360223 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 2.22209299 |
| 27 | MP0008004_abnormal_stomach_pH | 2.19445735 |
| 28 | MP0003868_abnormal_feces_composition | 2.18234186 |
| 29 | MP0000462_abnormal_digestive_system | 1.98918835 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.96234245 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.93471490 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.89705872 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.80272328 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.77993406 |
| 35 | MP0005409_darkened_coat_color | 1.74023137 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.71116588 |
| 37 | MP0002254_reproductive_system_inflammat | 1.71076541 |
| 38 | MP0002078_abnormal_glucose_homeostasis | 1.63199514 |
| 39 | MP0002928_abnormal_bile_duct | 1.62095041 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.58205065 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.53481684 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.52488252 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.51460479 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.46306475 |
| 45 | MP0000516_abnormal_urinary_system | 1.46305055 |
| 46 | MP0005367_renal/urinary_system_phenotyp | 1.46305055 |
| 47 | MP0001756_abnormal_urination | 1.44856910 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.43921110 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.40601347 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.40128240 |
| 51 | MP0002796_impaired_skin_barrier | 1.39882423 |
| 52 | MP0005408_hypopigmentation | 1.38624738 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.37292860 |
| 54 | MP0000538_abnormal_urinary_bladder | 1.33755264 |
| 55 | MP0003879_abnormal_hair_cell | 1.30603503 |
| 56 | MP0003941_abnormal_skin_development | 1.26990975 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.26821673 |
| 58 | MP0005332_abnormal_amino_acid | 1.26073213 |
| 59 | MP0001664_abnormal_digestion | 1.25159561 |
| 60 | MP0000613_abnormal_salivary_gland | 1.22426504 |
| 61 | MP0004270_analgesia | 1.18166264 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.17504072 |
| 63 | MP0000609_abnormal_liver_physiology | 1.14836420 |
| 64 | MP0003953_abnormal_hormone_level | 1.14773684 |
| 65 | MP0000681_abnormal_thyroid_gland | 1.14350847 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.12518054 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.11993952 |
| 68 | MP0002896_abnormal_bone_mineralization | 1.09376983 |
| 69 | MP0002822_catalepsy | 1.04121582 |
| 70 | MP0004147_increased_porphyrin_level | 1.02642256 |
| 71 | MP0001764_abnormal_homeostasis | 0.98882848 |
| 72 | MP0000566_synostosis | 0.98537967 |
| 73 | MP0000477_abnormal_intestine_morphology | 0.96843488 |
| 74 | MP0009379_abnormal_foot_pigmentation | 0.91309243 |
| 75 | MP0002168_other_aberrant_phenotype | 0.90972097 |
| 76 | MP0002098_abnormal_vibrissa_morphology | 0.90406948 |
| 77 | MP0003878_abnormal_ear_physiology | 0.88867179 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.88867179 |
| 79 | MP0003959_abnormal_lean_body | 0.88354374 |
| 80 | MP0009840_abnormal_foam_cell | 0.84220424 |
| 81 | MP0005448_abnormal_energy_balance | 0.84124637 |
| 82 | MP0005166_decreased_susceptibility_to | 0.83848575 |
| 83 | MP0002132_abnormal_respiratory_system | 0.83041622 |
| 84 | MP0002163_abnormal_gland_morphology | 0.82736495 |
| 85 | MP0001270_distended_abdomen | 0.81514968 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.78862938 |
| 87 | MP0005670_abnormal_white_adipose | 0.77038192 |
| 88 | MP0005501_abnormal_skin_physiology | 0.75596704 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.75447222 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.73332861 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 0.73269941 |
| 92 | MP0005310_abnormal_salivary_gland | 0.72976939 |
| 93 | MP0003186_abnormal_redox_activity | 0.71430645 |
| 94 | MP0006054_spinal_hemorrhage | 0.71092443 |
| 95 | MP0005334_abnormal_fat_pad | 0.69957874 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.69360450 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.69334210 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.68011855 |
| 99 | MP0003045_fibrosis | 0.67538734 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.66031777 |
| 101 | MP0000537_abnormal_urethra_morphology | 0.65599161 |
| 102 | MP0004484_altered_response_of | 0.63605867 |
| 103 | MP0001849_ear_inflammation | 0.63342675 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.63167283 |
| 105 | MP0003866_abnormal_defecation | 0.63013434 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.62924975 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.62447584 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.61858538 |
| 109 | MP0003011_delayed_dark_adaptation | 0.61801414 |
| 110 | MP0005535_abnormal_body_temperature | 0.61792310 |
| 111 | MP0002938_white_spotting | 0.60212668 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.59964753 |
| 113 | MP0004272_abnormal_basement_membrane | 0.58543393 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.58259674 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.57743633 |
| 116 | MP0005410_abnormal_fertilization | 0.56714615 |
| 117 | MP0000377_abnormal_hair_follicle | 0.56680990 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56447055 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.55070225 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.53794443 |
| 121 | MP0000383_abnormal_hair_follicle | 0.53142563 |
| 122 | MP0010030_abnormal_orbit_morphology | 0.52880044 |
| 123 | MP0008872_abnormal_physiological_respon | 0.52110060 |
| 124 | MP0001188_hyperpigmentation | 0.51848892 |
| 125 | MP0003315_abnormal_perineum_morphology | 0.51574208 |
| 126 | MP0003122_maternal_imprinting | 0.51433036 |
| 127 | MP0000598_abnormal_liver_morphology | 0.50958459 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.50922525 |
| 129 | MP0005395_other_phenotype | 0.50711378 |
| 130 | MP0010155_abnormal_intestine_physiology | 0.50396814 |
| 131 | MP0000534_abnormal_ureter_morphology | 0.49229920 |
| 132 | MP0001661_extended_life_span | 0.48991374 |
| 133 | MP0003119_abnormal_digestive_system | 0.47492325 |
| 134 | MP0004885_abnormal_endolymph | 0.47289666 |
| 135 | MP0002234_abnormal_pharynx_morphology | 0.46296267 |
| 136 | MP0001502_abnormal_circadian_rhythm | 0.45876452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.84527767 |
| 2 | Hypoglycemic seizures (HP:0002173) | 5.80733419 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.53932574 |
| 4 | Symptomatic seizures (HP:0011145) | 5.02644026 |
| 5 | Ketoacidosis (HP:0001993) | 4.60593879 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.26060258 |
| 7 | Hyperglycemia (HP:0003074) | 4.24774730 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 4.21084186 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.86442863 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 3.85946316 |
| 11 | Metabolic alkalosis (HP:0200114) | 3.82260054 |
| 12 | Late onset (HP:0003584) | 3.78634342 |
| 13 | Gout (HP:0001997) | 3.78173029 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72083407 |
| 15 | Decreased circulating renin level (HP:0003351) | 3.63884515 |
| 16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.61820193 |
| 17 | Abnormal pancreas size (HP:0012094) | 3.52720369 |
| 18 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.52417066 |
| 19 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.52417066 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.50670371 |
| 21 | Ketosis (HP:0001946) | 3.39749797 |
| 22 | Malnutrition (HP:0004395) | 3.26808544 |
| 23 | Abnormality of chloride homeostasis (HP:0011422) | 3.26493666 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.21059289 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.21059289 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 3.19504314 |
| 27 | Proximal tubulopathy (HP:0000114) | 3.14184995 |
| 28 | Hypolipoproteinemia (HP:0010981) | 3.13693485 |
| 29 | Abnormality of vitamin metabolism (HP:0100508) | 3.11760203 |
| 30 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.08238751 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01145299 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01145299 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01145299 |
| 34 | Focal segmental glomerulosclerosis (HP:0000097) | 2.99493424 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.94490626 |
| 36 | Abdominal distention (HP:0003270) | 2.94260262 |
| 37 | Insulin resistance (HP:0000855) | 2.83457179 |
| 38 | Abnormality of renin-angiotensin system (HP:0000847) | 2.80785098 |
| 39 | Exocrine pancreatic insufficiency (HP:0001738) | 2.80194346 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.79410355 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.77473385 |
| 42 | Abnormality of vitamin B metabolism (HP:0004340) | 2.76389291 |
| 43 | Large for gestational age (HP:0001520) | 2.75423499 |
| 44 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.72255116 |
| 45 | Flat acetabular roof (HP:0003180) | 2.72103848 |
| 46 | Fat malabsorption (HP:0002630) | 2.69952221 |
| 47 | Hypokalemia (HP:0002900) | 2.68669643 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67752847 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.67186313 |
| 50 | Increased circulating renin level (HP:0000848) | 2.64308496 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.62725873 |
| 52 | Chronic bronchitis (HP:0004469) | 2.61113602 |
| 53 | Hyperphosphatemia (HP:0002905) | 2.60594972 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.59604692 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.59604692 |
| 56 | Hyperkalemia (HP:0002153) | 2.58040945 |
| 57 | Unilateral renal agenesis (HP:0000122) | 2.57564204 |
| 58 | Osteomalacia (HP:0002749) | 2.56071006 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.54420159 |
| 60 | Hyperaldosteronism (HP:0000859) | 2.54129609 |
| 61 | Prolonged partial thromboplastin time (HP:0003645) | 2.52445539 |
| 62 | Glomerulosclerosis (HP:0000096) | 2.51860438 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.50551774 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.49179662 |
| 65 | Hyperglycinuria (HP:0003108) | 2.48961476 |
| 66 | Glomerulonephritis (HP:0000099) | 2.47539583 |
| 67 | Abnormal tarsal ossification (HP:0008369) | 2.46881275 |
| 68 | Retinal atrophy (HP:0001105) | 2.43595692 |
| 69 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.40174852 |
| 70 | Hypokalemic alkalosis (HP:0001949) | 2.39689435 |
| 71 | Glycosuria (HP:0003076) | 2.38382145 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.38382145 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.38031018 |
| 74 | Complement deficiency (HP:0004431) | 2.37205209 |
| 75 | Renal cortical cysts (HP:0000803) | 2.34514645 |
| 76 | Hypotension (HP:0002615) | 2.33825913 |
| 77 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.32093642 |
| 78 | Renal salt wasting (HP:0000127) | 2.30841910 |
| 79 | Nephritis (HP:0000123) | 2.30780011 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.29580588 |
| 81 | Abnormality of potassium homeostasis (HP:0011042) | 2.28212905 |
| 82 | Xanthomatosis (HP:0000991) | 2.27588532 |
| 83 | Pigmentary retinal degeneration (HP:0001146) | 2.27233327 |
| 84 | Hyperparathyroidism (HP:0000843) | 2.20813240 |
| 85 | Abnormality of the renal cortex (HP:0011035) | 2.20276610 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19598943 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.16883086 |
| 88 | Rickets (HP:0002748) | 2.16370087 |
| 89 | Hyponatremia (HP:0002902) | 2.14906028 |
| 90 | Enlarged kidneys (HP:0000105) | 2.14859019 |
| 91 | Widely patent fontanelles and sutures (HP:0004492) | 2.13657067 |
| 92 | Abnormal urine phosphate concentration (HP:0012599) | 2.13169142 |
| 93 | Alkalosis (HP:0001948) | 2.12981821 |
| 94 | Hypothermia (HP:0002045) | 2.12746989 |
| 95 | Abnormality of carpal bone ossification (HP:0006257) | 2.10842104 |
| 96 | Esophageal varix (HP:0002040) | 2.10083973 |
| 97 | Tachypnea (HP:0002789) | 2.07383978 |
| 98 | Pancreatitis (HP:0001733) | 2.06903980 |
| 99 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.04802671 |
| 100 | Congenital malformation of the right heart (HP:0011723) | 2.02260277 |
| 101 | Double outlet right ventricle (HP:0001719) | 2.02260277 |
| 102 | Protuberant abdomen (HP:0001538) | 2.01638655 |
| 103 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99343251 |
| 104 | Popliteal pterygium (HP:0009756) | 1.98989509 |
| 105 | Abnormal biliary tract morphology (HP:0012440) | 1.98338163 |
| 106 | Deep venous thrombosis (HP:0002625) | 1.97498031 |
| 107 | Hyperammonemia (HP:0001987) | 1.97289594 |
| 108 | Hyperglycinemia (HP:0002154) | 1.96253100 |
| 109 | Growth hormone excess (HP:0000845) | 1.96147613 |
| 110 | Metabolic acidosis (HP:0001942) | 1.95639077 |
| 111 | Increased purine levels (HP:0004368) | 1.90261476 |
| 112 | Hyperuricemia (HP:0002149) | 1.90261476 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 1.90125542 |
| 114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.90125542 |
| 115 | Goiter (HP:0000853) | 1.89824962 |
| 116 | Ileus (HP:0002595) | 1.89666838 |
| 117 | Nuclear cataract (HP:0100018) | 1.88334969 |
| 118 | Abnormality of magnesium homeostasis (HP:0004921) | 1.88286878 |
| 119 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.87510972 |
| 120 | Abnormality of glycine metabolism (HP:0010895) | 1.87510972 |
| 121 | Limb hypertonia (HP:0002509) | 1.87480460 |
| 122 | Vascular calcification (HP:0004934) | 1.87131683 |
| 123 | Tubulointerstitial fibrosis (HP:0005576) | 1.86525354 |
| 124 | Steatorrhea (HP:0002570) | 1.85360678 |
| 125 | Cystic liver disease (HP:0006706) | 1.85177837 |
| 126 | Sensorimotor neuropathy (HP:0007141) | 1.84929121 |
| 127 | Micronodular cirrhosis (HP:0001413) | 1.84835001 |
| 128 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84491169 |
| 129 | Abnormality of nucleobase metabolism (HP:0010932) | 1.82173283 |
| 130 | Subcapsular cataract (HP:0000523) | 1.81996202 |
| 131 | Amelogenesis imperfecta (HP:0000705) | 1.80483108 |
| 132 | Abnormality of permanent molar morphology (HP:0011071) | 1.79621030 |
| 133 | Abnormality of the dental root (HP:0006486) | 1.79621030 |
| 134 | Taurodontia (HP:0000679) | 1.79621030 |
| 135 | Abnormality of complement system (HP:0005339) | 1.79392440 |
| 136 | Progressive neurologic deterioration (HP:0002344) | 1.79075164 |
| 137 | Renal tubular acidosis (HP:0001947) | 1.78809003 |
| 138 | Adrenal overactivity (HP:0002717) | 1.78190571 |
| 139 | Abnormality of sodium homeostasis (HP:0010931) | 1.77139708 |
| 140 | Facial shape deformation (HP:0011334) | 1.77006822 |
| 141 | Potter facies (HP:0002009) | 1.77006822 |
| 142 | Syncope (HP:0001279) | 1.76805721 |
| 143 | Abnormality of renal excretion (HP:0011036) | 1.76713700 |
| 144 | Hyperphosphaturia (HP:0003109) | 1.76518228 |
| 145 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73806093 |
| 146 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.73636555 |
| 147 | Dehydration (HP:0001944) | 1.73582034 |
| 148 | Acute hepatic failure (HP:0006554) | 1.71921606 |
| 149 | Interstitial pulmonary disease (HP:0006530) | 1.71329510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.39932439 |
| 2 | MAPK15 | 4.25363080 |
| 3 | FRK | 3.97818873 |
| 4 | PASK | 3.08227706 |
| 5 | MST1R | 3.03532591 |
| 6 | TAOK3 | 2.87997725 |
| 7 | MAP3K2 | 2.72756806 |
| 8 | ERN1 | 2.70339686 |
| 9 | ACVR1B | 2.61792787 |
| 10 | BCKDK | 2.60357422 |
| 11 | EPHA2 | 2.52325618 |
| 12 | OXSR1 | 2.50678205 |
| 13 | MAP3K12 | 2.39783089 |
| 14 | CASK | 2.39215120 |
| 15 | SIK1 | 2.39048248 |
| 16 | WNK4 | 2.14877631 |
| 17 | IRAK3 | 2.10041221 |
| 18 | MAP2K2 | 2.02650070 |
| 19 | LMTK2 | 2.00188810 |
| 20 | WNK3 | 1.97977495 |
| 21 | AKT3 | 1.96859617 |
| 22 | MET | 1.81690803 |
| 23 | PIK3CG | 1.81682748 |
| 24 | LATS1 | 1.80548609 |
| 25 | HIPK2 | 1.80409791 |
| 26 | ERBB3 | 1.80058149 |
| 27 | PRKD3 | 1.78144668 |
| 28 | PTK6 | 1.73983917 |
| 29 | EPHA3 | 1.56812906 |
| 30 | STK24 | 1.44831217 |
| 31 | FGFR2 | 1.37568778 |
| 32 | MAP3K3 | 1.32621938 |
| 33 | FGFR4 | 1.32296461 |
| 34 | FLT3 | 1.32288750 |
| 35 | FER | 1.30409814 |
| 36 | NUAK1 | 1.27446501 |
| 37 | PTK2 | 1.23198780 |
| 38 | TRIB3 | 1.21491781 |
| 39 | STK38L | 1.18897391 |
| 40 | TNIK | 1.15928510 |
| 41 | TAOK1 | 1.15802127 |
| 42 | EPHA4 | 1.14005409 |
| 43 | IRAK1 | 1.08760530 |
| 44 | TRIM28 | 1.05361123 |
| 45 | MST4 | 1.04885843 |
| 46 | PBK | 1.03112944 |
| 47 | PAK4 | 0.98601118 |
| 48 | MAP3K1 | 0.94463275 |
| 49 | MAP2K1 | 0.90859266 |
| 50 | STK3 | 0.86476523 |
| 51 | EIF2AK3 | 0.81859166 |
| 52 | BMPR1B | 0.81132196 |
| 53 | MAPKAPK3 | 0.79717511 |
| 54 | PRKG2 | 0.78054161 |
| 55 | DYRK1B | 0.77314801 |
| 56 | PAK3 | 0.76631640 |
| 57 | RIPK1 | 0.76074948 |
| 58 | NLK | 0.75462165 |
| 59 | EPHB1 | 0.74282601 |
| 60 | SGK2 | 0.72442333 |
| 61 | BMPR2 | 0.71503106 |
| 62 | ERBB2 | 0.68782997 |
| 63 | PDGFRA | 0.68770743 |
| 64 | NME1 | 0.67486894 |
| 65 | PHKG2 | 0.67185216 |
| 66 | PHKG1 | 0.67185216 |
| 67 | PIK3CA | 0.65919092 |
| 68 | ICK | 0.64776557 |
| 69 | TESK1 | 0.61950063 |
| 70 | STK38 | 0.61898387 |
| 71 | PRKAA1 | 0.61140029 |
| 72 | PRKCE | 0.60931150 |
| 73 | PRKCH | 0.59124823 |
| 74 | CAMK1D | 0.58665942 |
| 75 | PRKCI | 0.58640203 |
| 76 | CHUK | 0.57904250 |
| 77 | TRPM7 | 0.57877713 |
| 78 | SGK3 | 0.57681891 |
| 79 | PINK1 | 0.56162826 |
| 80 | TEC | 0.54218911 |
| 81 | CSNK1G1 | 0.53781039 |
| 82 | CDC42BPA | 0.53726182 |
| 83 | GSK3A | 0.52164871 |
| 84 | BRAF | 0.51276082 |
| 85 | PRKAA2 | 0.50810014 |
| 86 | RPS6KA2 | 0.49772085 |
| 87 | EPHB2 | 0.49404630 |
| 88 | BRSK2 | 0.49403956 |
| 89 | MINK1 | 0.49291402 |
| 90 | SGK223 | 0.49030517 |
| 91 | SGK494 | 0.49030517 |
| 92 | MUSK | 0.48708917 |
| 93 | CAMKK2 | 0.48522715 |
| 94 | LRRK2 | 0.48063452 |
| 95 | FGFR1 | 0.47238936 |
| 96 | ROCK1 | 0.46837352 |
| 97 | SIK3 | 0.46378745 |
| 98 | CAMK2G | 0.45751861 |
| 99 | ERBB4 | 0.44517057 |
| 100 | JAK2 | 0.43905796 |
| 101 | MAP4K2 | 0.43437116 |
| 102 | DDR2 | 0.42654048 |
| 103 | IRAK2 | 0.40592975 |
| 104 | ZAP70 | 0.39602651 |
| 105 | CSNK1A1L | 0.39373765 |
| 106 | IGF1R | 0.39195794 |
| 107 | PDPK1 | 0.37307443 |
| 108 | PRKD2 | 0.37278358 |
| 109 | ROCK2 | 0.37235154 |
| 110 | FGFR3 | 0.36010738 |
| 111 | CAMK2D | 0.35760972 |
| 112 | GRK1 | 0.34995202 |
| 113 | SRC | 0.34453911 |
| 114 | YES1 | 0.34308596 |
| 115 | RPS6KB2 | 0.33716649 |
| 116 | SCYL2 | 0.32838995 |
| 117 | CSK | 0.32782894 |
| 118 | PRKCZ | 0.32583379 |
| 119 | ITK | 0.31782558 |
| 120 | NTRK1 | 0.31741295 |
| 121 | EIF2AK1 | 0.31512765 |
| 122 | PRKACG | 0.31133024 |
| 123 | CSNK1A1 | 0.30722640 |
| 124 | STK39 | 0.30541226 |
| 125 | PDGFRB | 0.30387404 |
| 126 | BCR | 0.30094508 |
| 127 | DAPK2 | 0.29868229 |
| 128 | CSNK1G3 | 0.29355337 |
| 129 | MAP2K6 | 0.29204877 |
| 130 | NTRK3 | 0.28482940 |
| 131 | NEK9 | 0.28425984 |
| 132 | PRKCA | 0.27942375 |
| 133 | AKT2 | 0.26564964 |
| 134 | CAMK2B | 0.26458539 |
| 135 | MAP3K7 | 0.25462831 |
| 136 | JAK1 | 0.25401771 |
| 137 | ZAK | 0.25121454 |
| 138 | TIE1 | 0.24574890 |
| 139 | MTOR | 0.24440184 |
| 140 | MYLK | 0.23994160 |
| 141 | MARK3 | 0.23325109 |
| 142 | LATS2 | 0.23031098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.76540356 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.48958017 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.64803784 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.53380286 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.41035867 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30640619 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.24503818 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03530688 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.99520429 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.98577517 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.77254921 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73134047 |
| 13 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.70938635 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68224781 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60213575 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59813746 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57828183 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53252176 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.51675208 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49661746 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43040357 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.42958280 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.42897365 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42206492 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.41895738 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33278174 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32666608 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31041854 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.30413576 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28045379 |
| 31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25210350 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24049384 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21348848 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19891828 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19752851 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19559490 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17608845 |
| 38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.17297291 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17114970 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.16681399 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14958753 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13310015 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05079133 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02193220 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02051373 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01874039 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00204181 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99028611 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98887739 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98590912 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.98237523 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92910394 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.91289989 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86739872 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85804808 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84945408 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84123818 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.84085525 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82367491 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81279939 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81196735 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.80907789 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80284159 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79472787 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78713194 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.74072383 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73300610 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72618507 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71575288 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71372553 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69523812 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64095445 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60647000 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55363780 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54340593 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.54070173 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.52150643 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51858007 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47794134 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47543071 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46582156 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46545415 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45822052 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44927788 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43784876 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43091613 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42603411 |
| 88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42400005 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42058481 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.40403424 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37792667 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35387863 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34539415 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34479498 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33569740 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32863459 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32857902 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32235879 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31162750 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30575463 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29487064 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29407109 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29119553 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26869439 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.25806566 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.25786316 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25670386 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23787774 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22855380 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.22193141 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22016594 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21829821 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21514708 |
| 114 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21058025 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20938654 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.17963200 |

